Systemic treatment of metastatic squamous cell carcinoma of the head and neck: proposal for management changes.
Fiche publication
Date publication
mars 2021
Journal
Current opinion in oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BOREL Christian
Tous les auteurs :
Peyrade F, Borel C, Daste A, Even C, Saada-Bouzid E, Guigay J
Lien Pubmed
Résumé
Worldwide, head and neck carcinomas account for 5% of all malignancies. Two-thirds of patients relapse after initial multimodal therapy. Until early 2010, the median overall survival (OS) of metastatic patients was about 10 months.
Référence
Curr Opin Oncol. 2021 Mar 26;: